Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis
Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...
How do you know a surgeon in training is ready to operate independently?
I am trying to find a cheap, easy and reliable way to grade the skill of surgeons in training. Experts can...
Ebola video voice-over recording in 10 African local languages
Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...